Multicenter outbreak reveals high regional dominance of plasmid-encoded bla OXA-72 in Carbapenem-resistant Acinetobacter baumannii, highlighting urgent surveillance needs.
Carbapenem-resistant Acinetobacter baumannii (CRAb) causes hard-to-control healthcare outbreaks, but the mobile resistance determinants that sustain regional spread are often underrecognized. We characterized 70 CRAb isolates from 11 hospitals in southern Poland (2019–2022) using whole-genome sequencing and core genome multilocus sequence typing (cgMLST), with reconstruction of carbapenemase context and plasmid structure. All isolates belonged to international clone 2 (IC2; ST2, Pasteur scheme) or to ST425 ( n = 47), ST195 ( n = 19), ST208 ( n = 2), and ST348 ( n = 1) according to the Oxford scheme. In silico KL/OCL typing further differentiated the collection. All isolates were OCL18, whereas the K-locus distribution was dominated by KL125 ( n = 48) and KL3 ( n = 19), with two KL2 isolates and one KL9 isolate. bla OXA-72 was detected in 50/70 isolates (71.4%), indicating an atypically high regional dominance. The OXA-72-encoding gene was carried on the same ~10.9 kb GR2/repAci1 plasmid (p398AB) in all isolates, which was sequence-identical across centers and contained two oppositely oriented copies of bla OXA-72 . Transformation of p398AB into susceptible A. baumannii ATCC17978 conferred a carbapenem-resistant phenotype. cgMLST identified a large multicenter cluster of bla OXA-72 -positive isolates spanning multiple cities and hospitals, supporting inter-facility dissemination of a successful IC2 lineage, together with a conserved resistance plasmid. The strict conservation of p398AB during regional spread provides a practical target for rapid molecular screening in outbreak investigations. In contrast, bla OXA-23 and a novel bla OXA-23 -like variant ( bla OXA-1223 ) were confined to a minority of isolates. Overall, these data highlight an unusual dominance of plasmid-encoded bla OXA-72 in a multicenter IC2 outbreak and underscore the need for surveillance integrating clonal relatedness with tracking of transferable resistance plasmids.
No takes yet. Share an insight, caveat, or question.
Kasperski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: